|
HypaqueDrug - Hypaque The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
Active Ingredient(s) -
Diatrizoate Sodium
Strength -
25%
Applicant -
GE HEALTHCARE
New Drug Application (NDA) Number -
009561
Product Number -
003
Therapeutic Equivalence (TE) Code -
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Ge Healthcare
Hypaque
Gastrografin 66%;10% Solution; Oral, Rectal
Gastrovist 66%;10% Solution; Oral, Rectal Md-gastroview 66%;10% Solution; Oral, Rectal Sinografin 52.7%;26.8% Solution; Intrauterine Hypaque 100% For Solution; Oral, Rectal Hypaque 25% Injectable; Injection Renografin-60 52%;8% Injectable; Injection Renografin-76 66%;10% Injectable; Injection Renovist 34.3%;35% Injectable; Injection Renovist Ii 28.5%;29.1% Injectable; Injection NewDrugInformation |